#4533 on the rich list of 14,644 insiders
Patrick O'Brien
COO at Arrowhead Pharmaceuticals. Based in Pasadena, California.
$23.9M
in disclosed stock, +$296K (+1.25%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4533rd of 14,644
- Companies held
- 1
- Largest holding
- ARWR, 100.0% of total
- Latest SEC filing
- Jan 6, 2026
What the $23.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ARWR Common Stock | Directly | 547,408 | $43.65 | $23.9M | 100.0% | Form 4, Jan 6, 2026 |
Share counts are the amounts Patrick O'Brien reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Sold | ARWR | 46 | $68.00 | $3K | View |
| Jan 5, 2026 | Sold | ARWR | 4,368 | $61.20 | $267K | View |
| Jan 5, 2026 | Sold | ARWR | 6,164 | $62.23 | $384K | View |
| Jan 5, 2026 | Sold | ARWR | 13,451 | $62.96 | $847K | View |
| Jan 5, 2026 | Sold | ARWR | 11,842 | $63.84 | $756K | View |
| Jan 5, 2026 | Sold | ARWR | 2,700 | $64.44 | $174K | View |
| Jan 5, 2026 | Sold | ARWR | 900 | $66.01 | $59K | View |
| Jan 5, 2026 | Sold | ARWR | 313 | $68.00 | $21K | View |
| Jan 5, 2026 | Sold | ARWR | 600 | $61.12 | $37K | View |
| Jan 5, 2026 | Sold | ARWR | 900 | $62.25 | $56K | View |
| Jan 5, 2026 | Sold | ARWR | 5,873 | $62.91 | $369K | View |
| Jan 5, 2026 | Sold | ARWR | 2,336 | $64.04 | $150K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4530 | Michael Gaubert Executive Chairman, Strive. Dallas, TX | $23.9M |
| 4531 | John Q. Doyle President and CEO, Marsh & McLennan Companies. New York, NY | $23.9M |
| 4532 | DeEtte Gray President, US Operations, CACI International. Reston, VA | $23.9M |
| 4533 | Patrick O'Brien COO, Arrowhead Pharmaceuticals. Pasadena, CA | $23.9M |
| 4534 | George Poste Director, Caris Life Sciences. Irving, TX | $23.9M |
| 4535 | Robert W. Holmes Director, Bank First. Manitowoc, WI | $23.9M |
| 4536 | John S Kellington EVP, Chief Info Off. -Sub, Cincinnati Financial. Fairfield, OH | $23.9M |
Other Arrowhead Pharmaceuticals insiders
All ARWR insiders- Christopher Anzalone$166MChief Executive Officer. #1025 overall
- Kenneth Myszkowski$19.9MChief Financial Officer. #5216 overall
- James Hamilton$9.9MChief Medical Officer. #8850 overall
- Javier San Martin$8.7MChief Medical Officer. #9742 overall
- Daniel Joseph Apel$7.1MChief Financial Officer. #11271 overall
- Tracie Oliver$5.5MChief Commercial Officer. #13467 overall
Questions
How much stock does Patrick O'Brien own?
Patrick O'Brien holds $23,894,359 in listed stock based on SEC filings and current prices, mostly Arrowhead Pharmaceuticals (ARWR). That ranks 4533rd on the Stock Rich List.
Is this Patrick O'Brien's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Patrick O'Brien last buy or sell stock?
The most recent open-market trade on file is a sale of 46 ARWR shares on Jan 5, 2026 at $68.00.